DOI:
10.1055/s-00000034
Klinische Pädiatrie
LinksClose Window
References
Ladenstein R, Poetschger U, Pearson AD. et al.
Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi-arm, open-label, phase 3 tria.
Lancet Oncol 2017;
DOI: 10.1016/S1470-2045(17)30070-0.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.